Pharmacologic Management of Insomnia

Insomnia prescribing requires more than choosing a “sleep aid”, it requires matching drug mechanism and pharmacokinetics to the patient’s symptom pattern, comorbidities, and safety risks. This APRN-focused pharmacology course reviews FDA-approved and commonly used off-label options for insomnia, with practical guidance on selecting agents for sleep onset versus sleep maintenance complaints, choosing doses in older adults, minimizing next-day impairment, and reducing harm in patients at risk for falls, respiratory compromise, complex polypharmacy, or substance use. Learners will apply guideline-supported decision pathways, interpret key safety signals and labeling considerations for newer dual orexin receptor antagonists, and use structured tapering and monitoring approaches to reduce long-term hypnotic exposure when appropriate. Pediatric and adolescent prescribing considerations are also addressed, with emphasis on rational selection, monitoring, and risk mitigation.